Birgit Volgger

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

Éric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist et al. · Journal of Clinical Oncology · 2010 · 572 citations

Medicine, Oncology, Pharmacology +17

Diagnostic accuracy of guided cervical biopsies: a prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen

Christian Zuchna, Martina Hager, Barbara Tringler et al. · American Journal of Obstetrics and Gynecology · 2010 · 93 citations

Medicine, Gynecology, Pathology +17

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

J. Alexandre, Chris Brown, David Coeffic et al. · British Journal of Cancer · 2012 · 44 citations · Full text

Medicine, Gynecology, Oncology +12

Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study

Christine Brunner, Marjan Arvandi, Christian Marth et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Breast Oncology +10

Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum–taxane therapy: A phase II Austrian AGO study

Edgar Petru, Lukas Angleitner-Boubenizek, Alexander Reinthaller et al. · Gynecologic Oncology · 2006 · 30 citations

Medicine, Oncology, Pharmacology +17